Related Experiment Video
Updated: Aug 13, 2026
07:29
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
[Multicenter evaluation of four homogenous LDL-cholesterol assays]
P Bayer1, F Veinberg, R Couderc
1Laboratoire de biochimie et Centre clinicobiologique des lipides (Arcol), Groupe Hospitalier L'Archet, Nice. bayer.p@chu-nice.fr
Annales De Biologie Clinique
|February 4, 2005
Summary
New direct LDL cholesterol (LDL-C) assays offer improved accuracy and convenience over the traditional Friedewald calculation, especially for patients with high triglycerides or abnormal lipoproteins. These methods provide a reliable alternative for cardiovascular risk assessment.
Area of Science:
- Clinical Chemistry
- Cardiovascular Diagnostics
- Lipid Metabolism
Background:
- International guidelines highlight the critical role of LDL cholesterol (LDL-C) assays in managing cardiovascular risk.
- The Friedewald formula is widely used for LDL-C calculation but has limitations, particularly with elevated triglycerides (TG > 4.5 mmol/L) or dyslipidemias.
- These limitations necessitate the development of direct LDL-C measurement methods for improved accuracy and broader applicability.
Purpose of the Study:
- To evaluate the performance of four new direct LDL-C assays (Daiichi, Denka Seiken, Kyowa, Wako) in a multicenter setting.
- To compare the accuracy and reproducibility of direct assays against the Friedewald calculation and reference methods.
- To assess the specificity and reliability of direct LDL-C assays in various dyslipidemic conditions.
Main Methods:
- A multicenter evaluation involving eight laboratories and 45 serum samples with TG < 3.1 mmol/L.
- Comparison of four direct LDL-C assays (Daiichi, Denka Seiken, Kyowa, Wako) with Friedewald calculation and beta-quantification.
- Testing of assay specificity using spiked lipoproteins and evaluation in patients with type III hyperlipoproteinemia.
Main Results:
- Three direct methods (Daiichi, Kyowa, Wako) demonstrated significantly improved interlaboratory reproducibility compared to Friedewald calculation.
- All tested direct methods showed strong correlation with beta-quantification, though bias varied among assays.
- VLDL-C/TG ratio influenced bias in Daiichi, Kyowa, and Wako assays; Denka Seiken was most reliable in type III hyperlipoproteinemia.
Conclusions:
- New direct LDL-C assays represent a significant technological advancement, offering enhanced analytical performance and convenience.
- These direct methods overcome the limitations of Friedewald calculation, providing a more reliable alternative for diagnosing and monitoring hyperlipidemic patients.
- Despite some assay-specific variability, direct LDL-C measurement is suitable for routine clinical use, particularly within specified triglyceride limits.
